showed that the TAAb combination of P53, c‐myc, HER2, NY‐ESO‐1, CAGE, MUC1, and GBU4‐5 was positive in the peripheral blood samples of 76% of advanced lung cancer patients [28]. Here, ERBB2 is linked to lung carcinoma.